cediranib

AstraZeneca and Merck's string of Lynparza successes ends in ovarian cancer
BioPharma Dive
Thu, 03/12/20 - 12:58 pm
AstraZeneca
Merck
cediranib
ovarian cancer
clinical trials
Lynparza
New insight into a struggling AstraZeneca anti-VEGF drug could expand its use in cancer
Fierce Biotech
Fri, 05/17/19 - 07:20 pm
AstraZeneca
Avastin
anti-VEGF
cediranib
Can a little known drug in AstraZeneca's pipeline make a comeback as a PARP add-on? Yale scientists explain how
Endpoints
Thu, 05/16/19 - 11:51 am
AstraZeneca
cediranib
ovarian cancer
Yale
PARP inhibitors
Two experimental AstraZeneca drugs show promise in ovarian cancer
Yahoo/Reuters
Sat, 05/31/14 - 10:26 am
AstraZeneca
ovarian cancer
olaparib
cediranib